Shenzhen Rivaroxaban Co.,Ltd
Home
About us
Products
Rivaroxaban
Pharmaceutical Intermediates
Tegprazan
VeMurafenib
Anti-diabetic
Antiviral Drug
Antidepressants
Anti-cancer Drugs
High Polymer Materials
Complementary Medicines
Cardiovascular Medications
News
Blog
Contact us
Language
English
Français
Deutsch
Español
Italiano
Português
日本語
한국어
Русский
Home
>
News
LATEST NEWS
Antidepressants: Two million taking them for five years or more
How cancer drugs work
Anti
For Your Patients: Breast Cancer Basics
Pfizer axes RSV, eczema, sickle cell and cancer drugs in cull
Jun 25, 2023
Antidepressants: Two million taking them for five years or more
read more +
Jun 23, 2023
How cancer drugs work
read more +
Jun 21, 2023
Anti
read more +
Jun 19, 2023
For Your Patients: Breast Cancer Basics
read more +
Jun 17, 2023
Pfizer axes RSV, eczema, sickle cell and cancer drugs in cull
read more +
Jun 15, 2023
Study cited by Texas judge in abortion
read more +
Jun 13, 2023
FDA approves new treatment for advanced prostate cancer
read more +
Jun 11, 2023
Cancer Drug Selectively Kills Tumor Cells in Preclinical Study
read more +
Jun 09, 2023
Understanding the Role of Liquid Crystal Polymer in Telecommunication Technology
read more +
Jun 07, 2023
Interactive Networks For Capturing Gas With High Selectivity
read more +
Jun 05, 2023
The Use of AFM for Polymer Science
read more +
Jun 03, 2023
Understanding Battery Types, Components and the Role of Battery Material Testing in Development and Manufacture
read more +
first
1
2
3
4
5
last